Jan de Witte - 10 Mar 2023 Form 4/A - Amendment Insider Report for INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Role
President & CEO, Director
Signature
/s/ Eric Schwartz; Attorney-in-Fact
Issuer symbol
IART
Transactions as of
10 Mar 2023
Net transactions value
-$10,838
Form type
4/A - Amendment
Filing time
13 Oct 2023, 16:25:34 UTC
Date Of Original Report
14 Mar 2023
Previous filing
15 Feb 2023
Next filing
02 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IART Common Stock Options Exercise $0 +205 +4.1% $0.000000 5,211 11 Mar 2023 Direct F1
transaction IART Common Stock Tax liability $10,838 -205 -3.9% $52.87 5,006 11 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IART Restricted Stock Units Options Exercise $0 -205 -0.2% $0.000000 99,828 11 Mar 2023 Common Stock 205 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was inadvertently omitted from the Reporting Person's Form 4 filed on March 14, 2023.
F2 The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/11/2022 which shall be delivered to the Reporting Person within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation.

Remarks:

Pursuant to Instruction 9 to Form 4, the Reporting Person has omitted from this amendment to the Form 4 the transaction information with respect to the other shares of the Issuer that were reported in the initial filing of the Form 4 and which are not being amended hereby.